Literature DB >> 19679734

An alternative approach to medical genetics based on modern evolutionary biology. Part 2: retroviral symbiosis.

Frank P Ryan1.   

Abstract

Mesh:

Year:  2009        PMID: 19679734      PMCID: PMC2726814          DOI: 10.1258/jrsm.2009.090183

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  70 in total

1.  Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene.

Authors:  C N Ting; M P Rosenberg; C M Snow; L C Samuelson; M H Meisler
Journal:  Genes Dev       Date:  1992-08       Impact factor: 11.361

2.  An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.

Authors:  J L Blond; D Lavillette; V Cheynet; O Bouton; G Oriol; S Chapel-Fernandes; B Mandrand; F Mallet; F L Cosset
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Why repetitive DNA is essential to genome function.

Authors:  James A Shapiro; Richard von Sternberg
Journal:  Biol Rev Camb Philos Soc       Date:  2005-05

Review 4.  SINEs and LINEs: symbionts of eukaryotic genomes with a common tail.

Authors:  K Ohshima; N Okada
Journal:  Cytogenet Genome Res       Date:  2005       Impact factor: 1.636

5.  Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

Authors:  M Barbulescu; G Turner; M I Seaman; A S Deinard; K K Kidd; J Lenz
Journal:  Curr Biol       Date:  1999-08-26       Impact factor: 10.834

6.  A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.

Authors:  Robert J Gifford; Aris Katzourakis; Michael Tristem; Oliver G Pybus; Mark Winters; Robert W Shafer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

7.  Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.

Authors:  Sandra Blaise; Nathalie de Parseval; Laurence Bénit; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

Review 8.  Retroelements and the human genome: new perspectives on an old relation.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

9.  Role of endogenous reverse transcriptase in murine early embryo development.

Authors:  Carmine Pittoggi; Ilaria Sciamanna; Elisabetta Mattei; Rosanna Beraldi; Anna Maria Lobascio; Antonello Mai; Maria Giovanna Quaglia; Rodolfo Lorenzini; Corrado Spadafora
Journal:  Mol Reprod Dev       Date:  2003-11       Impact factor: 2.609

10.  Endonuclease-independent insertion provides an alternative pathway for L1 retrotransposition in the human genome.

Authors:  Shurjo K Sen; Charles T Huang; Kyudong Han; Mark A Batzer
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

View more
  4 in total

1.  Widespread horizontal gene transfer from double-stranded RNA viruses to eukaryotic nuclear genomes.

Authors:  Huiquan Liu; Yanping Fu; Daohong Jiang; Guoqing Li; Jiatao Xie; Jiasen Cheng; Youliang Peng; Said A Ghabrial; Xianhong Yi
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

Review 2.  An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

3.  Detection of the human endogenous retrovirus ERV3-encoded Env-protein in human tissues using antibody-based proteomics.

Authors:  Chen Fei; Christina Atterby; Per-Henrik Edqvist; Fredrik Pontén; Wei Wei Zhang; Erik Larsson; Frank P Ryan
Journal:  J R Soc Med       Date:  2013-11-21       Impact factor: 5.344

4.  Human endogenous retroviruses in multiple sclerosis: potential for novel neuro-pharmacological research.

Authors:  F P Ryan
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.